Willenbring Lab »  Alumni »  Surgical Residents »  Jack Harbell, M.D.

Jack Harbell, M.D.

Clinical Instructor
Abdominal Transplant Fellow (PGY-7)
Division of Transplant Surgery

Contact Information

Open Popup
  • University of Washington, Seattle, Washington, B.S. Microbiology, 2003
  • New York University School of Medicine, New York, New York, M.D. 2008
  • Transplantation
  • Liver Cell Therapy
  • Liver Regeneration

I attended the University of Washington as an undergraduate where I received my degree in Microbiology. During that time, I worked with a faculty member in the Microbiology Department, Dr. Michael Lagunoff, studying the effects of Kaposi's Sarcoma-Associated Herpesvirus (KSHV) on cancer transformation in endothelial cells. Following graduation from the University of Washington, I continued my work in Dr. Lagunoff's lab as a technician, conducting additional experiments related to protein-protein interactions, and regulation of host cell processes following KSHV infection.

In 2004, I began medical school at New York University School of Medicine. I continued to work on basic virology research with a faculty member at NYU, Ian Mohr, investigating the effects of KSHV reactivation on regulation of protein translation. During my third and fourth years of medical school, I became more interested in pursuing a career in surgery, specifically transplantation.

As a surgical resident at UCSF, I worked with Dr. Holger Willenbring to develop potential sources of autologous cell therapy for treatment of liver disease.

  • SUS/Ethicon Resident Research Scholarship
  1. Wisel SA, Gardner JM, Roll GR, Harbell J, Freise CE, Feng S, Kang SM, Hirose R, Kaufman DB, Posselt A, Stock PG. Pancreas-after-Islet (PAI) transplantation in non-uremic Type 1 diabetes: A strategy for restoring durable insulin independence. Am J Transplant. 2017 May 10. View in PubMed
  2. Morgan TA, Smith-Bindman R, Harbell J, Kornak J, Stock PG, Feldstein VA. US Findings in Patients at Risk for Pancreas Transplant Failure. Radiology. 2016 Jul; 280(1):281-9. View in PubMed
  3. Espejel S, Eckardt S, Harbell J, Roll GR, McLaughlin KJ, Willenbring H. Brief report: Parthenogenetic embryonic stem cells are an effective cell source for therapeutic liver repopulation. Stem Cells. 2014 Jul; 32(7):1983-8. View in PubMed
  4. Zhu S, Rezvani M, Harbell J, Mattis AN, Wolfe AR, Benet LZ, Willenbring H, Ding S. Mouse liver repopulation with hepatocytes generated from human fibroblasts. Nature. 2014 Apr 3; 508(7494):93-7. View in PubMed
  5. Harbell J, Terrault NA, Stock P. Solid organ transplants in HIV-infected patients. Curr HIV/AIDS Rep. 2013 Sep; 10(3):217-25. View in PubMed
  6. Harbell J, Fung J, Nissen N, Olthoff K, Florman SS, Hanto DW, Light J, Bartlett ST, Tzakis AG, Pearson TC, Barin B, Roland ME, Stock PG. Surgical complications in 275 HIV-infected liver and/or kidney transplantation recipients. Surgery. 2012 Sep; 152(3):376-81. View in PubMed
  7. Arias C, Walsh D, Harbell J, Wilson AC, Mohr I. Activation of host translational control pathways by a viral developmental switch. PLoS Pathog. 2009 Mar; 5(3):e1000334. View in PubMed
Publications provided by UCSF Profiles, powered by CTSI at UCSF. View profile of Jack Harbell, M.D.
Please note: UCSF Profiles publications are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact CTSI for help.